EC Microbiology

Review Article Volume 18 Issue 2 - 2022

Overview of Bronchiolitis: Diagnosis and Management

Hani Abdullah Al Hashmi1*, Afnan Ahmed Al Jehani2, Rakan Jamel Alsahagi3, Fatimah Salman Alnasser4, Faisal Abdullah Alqathanin5, Sultan Hamed Alanazy6, Mohammed Eidhah Ahmed Alzahrani7, Hussain Obiad Almutairi8, Marwah Naji Almouwalled9, Wessam Ali Alsaihati4, Rawah Sadaga Doush9, Nejood mosab waggas1, Tasleem Khoudier Alabdullatif10 and Abdulrahman Ibrahim Alrefaei11

1King Abdulaziz Hospital – Jeddah

2Royal Comission Medical Center – Yanbu

3King Abdulaziz Almajer – Jeddah

4Safwa Primary Health Care – Safwa

5King Khalid University – Abha

6Aliman General Hospital – Riyadh

7King Fahad Hospital – Albaha

8Diabetic Center - Hafar Albatin

9Ibn Sina National Collage – Jeddah

10Northern Border University - Arar

11Cairo university – Cairo

*Corresponding Author:Hani Abdullah Al Hashmi, King Abdulaziz Hospital – Jeddah.
Received: December 10, 2021; Published:January 21, 2022



Background: Inflammation of the lower respiratory tract, i.e., the bronchioles, is known as Bronchiolitis. Viruses are almost always responsible for this infection, and it usually affects very young children. Bronchiolitis also happens to be the commonest cause of the hospitalization of children in many countries. In this article, we summarise the epidemiology, pathophysiology, and diagnosis and emphasize guidelines for the treatment of Bronchiolitis.

Aim of the Work: An overview is aimed at describing bronchiolitis in terms of etiology, epidemiology, pathophysiology, clinical features, and various management modalities.

Methodology: The review is a comprehensive research of PUBMED from the year 2003 to 2021

Conclusion: Hospitalization due to Bronchiolitis is quite common among infants. The most common causative factor is the Respiratory Syncytial Virus (RSV), among other viruses. Infection typically starts with fever and rhinorrhea, followed by wheezing and hypoxia in severe cases—common management techniques minimal handling, maintenance of oxygen saturation, fluid balance, and nutrition. Inhalation with saline and epinephrine are also other modes of treatment, but their efficacy is yet to be proved. In cases of respiratory failure, invasive and non-invasive ventilation may also be required

Keywords: Bronchiolitis; RSV Infection; Bronchodilator

  1. Nagakumar P and Doull I. “Current therapy for Bronchiolitis”. Archives of Disease in Childhood9 (2012): 827-830.
  2. Wagner T. “Bronchiolitis”. Pediatrics in Review10 (2009): 386-395.
  3. Wainwright C. “Acute viral Bronchiolitis in children-a very common condition with few therapeutic options”. Paediatric Respiratory Reviews 1 (2010): 39-45.
  4. Carroll K N., et al. “Increasing burden and risk factors for bronchiolitis-related medical visits in infants enrolled in a state health care insurance plan”. Pediatrics 1 (2008): 58-64.
  5. Fjaerli H O., et al. “Hospitalisations for respiratory syncytial virus bronchiolitis in Akershus, Norway, 1993–2000: a population-based retrospective study”. BMC Pediatrics 1 (2004): 1-7.
  6. Silver A H and Nazif J M. “Bronchiolitis”. Pediatrics in Review 11 (2019): 568-576.
  7. Panickar J R., et al. “Trends in deaths from respiratory illness in children in England and Wales from 1968 to 2000”. Thorax12 (2005): 1035-1038.
  8. Zorc JJ and Hall CB. “Bronchiolitis: recent evidence on diagnosis and management”. Pediatrics 2 (2010): 342-349.
  9. Scottish Intercollegiate Guidelines Network: Bronchiolitis in Children.
  10. Subcommittee on Diagnosis and Management of Bronchiolitis. Diagnosis and management of bronchiolitis”. Pediatrics4 (2006): 1774-1793.
  11. Mandelberg A and Amirav I. “Hypertonic saline or high volume normal saline for viral bronchiolitis: mechanisms and rationale”. Pediatric Pulmonology1 (2010): 36-40.
  12. Hartling L., et al. “Epinephrine for bronchiolitis”. Cochrane Database of Systematic Reviews 6 (2011).
  13. Van Woensel J B M., et al. “Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus”. Thorax5 (2003): 383-387.
  14. Spurling G K., et al. “Antibiotics for bronchiolitis in children”. Cochrane Database of Systematic Reviews 6 (2011).
  15. Greenough A. “Role of ventilation in RSV disease: CPAP, ventilation, HFO, ECMO”. Paediatric Respiratory Reviews 10 (2009): 26-28.
  16. Thorburn K and Ritson P. “Heated, humidified high-flow nasal cannula therapy in viral bronchiolitis-Panacea, passing phase, or progress?”. Pediatric Critical Care Medicine6 (2012): 700-701.
  17. Lazner M R., et al. “Noninvasive ventilation for severe bronchiolitis: Analysis and evidence”. Pediatric Pulmonology9 (2012): 909-916.
  18. Anne R P and Murki S. “Noninvasive respiratory support in neonates: a review of current evidence and practices”. Indian Journal of Pediatrics (2021): 1-9.
  19. Øymar K., et al. “Acute bronchiolitis in infants, a review”. Scandinavian Journal of Trauma, Resuscitation, and Emergency Medicine1 (2014): 1-10.
  20. Mikalsen IB., et al. “The outcome after severe bronchiolitis is related to gender and virus”. Pediatric Allergy and Immunology4 (2012): 391-398.

Hani Abdullah Al Hashmi., et al. Overview of Bronchiolitis: Diagnosis and Management. EC Microbiology  18.2 (2022):07-13.